|
|
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CH |
First Approval Date28 Apr 1998 |
[Translation] JC002 Comparative Pharmacokinetics Clinical Trial
主要研究目的:评价空腹状态下JC002药代动力学的特性。
次要研究目的:评价JC002服用口感与已上市对照制剂是否存在差异;并观察JC002在健康成人受试者中的安全性。
[Translation] Main research purpose: To evaluate the pharmacokinetic properties of JC002 in the fasting state.
Secondary research purpose: To evaluate whether there is any difference in the taste of JC002 and the marketed control preparation; and to observe the safety of JC002 in healthy adult subjects.
[Translation] JC001 bioequivalence test (high dose group)
验证高剂量JC001与800mg布洛芬注射液BE等效
[Translation] Verified that high-dose JC001 is BE equivalent to 800mg ibuprofen injection
[Translation] JC001 bioequivalence test (low dose group)
验证低剂量JC001与400mg布洛芬注射液BE等效
[Translation] Verify that low-dose JC001 is BE equivalent to 400mg ibuprofen injection
100 Clinical Results associated with Beijing Jiacheng Medicine Co Ltd
0 Patents (Medical) associated with Beijing Jiacheng Medicine Co Ltd
100 Deals associated with Beijing Jiacheng Medicine Co Ltd
100 Translational Medicine associated with Beijing Jiacheng Medicine Co Ltd